EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap

Keiichiro Matoba

Endocrine Journal · 2023

DOI: 10.1507/endocrj.ej23-0282 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Endocrine Journal, 2023. Verfasst von Keiichiro Matoba. Beteiligte Einrichtung: Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan. Hauptthemen laut MEDLINE: Diabetes Mellitus, Diabetic Nephropathies. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy is a public health problem worldwide. Our understanding of the molecular machinery, as well as the clinical therapies for diabetic nephropathy, has evolved dramatically in recent years. However, even with this progress, there are residual risks of kidney failure and cardiovascular events in patients with diabetes. Rho-associated, coiled-coil-containing protein kinase (ROCK) is activated in response to various pathologic stimuli in the context of diabetes. The contribution of ROCK has been investigated in vivo using gene deletion rodent models and specific inhibitors, which are providing key insights into the pathologic function of ROCK in diabetic nephropathy. ROCK has two isoforms, ROCK1 and ROCK2. Both isoforms are expressed in the kidney, including mesangial cells, podocytes, and endothelial cells. ROCK1 blunts AMP-activated protein kinase (AMPK), while ROCK2 negatively regulates peroxisome proliferator-activated receptor α (PPARα) to inhibit fatty acid oxidation, both of which lead to structural and functional impairment of glomeruli in diabetes. Of note, ROCK signaling is activated in the kidney of animal models and patients with diabetes. In addition, an observational study has shown that fasudil hydrochloride, an ATP-competitive selective ROCK inhibitor, significantly attenuated proteinuria among patients with diabetes. These findings highlight the promising prospects for the development of a ROCK-centered approach against the progression of diabetic nephropathy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes MellitusDiabetic NephropathiesAnimalsEndothelial CellsKidneyProtein Kinase Inhibitorsrho-Associated KinasesSignal TransductionMice

Stichwörter der Autor:innen

Chronic kidney diseaseDiabetesDiabetic nephropathyRho-associated, coiled-coil-containing protein kinase (ROCK)

Substanzen

Protein Kinase Inhibitorsrho-Associated Kinases

Autor:innen und Institutionen

  • Division of Diabetes, Metabolism and Endocrinology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo 105-8461, Japan.

Zitieren

APA

Matoba, K. (2023). Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap. Endocrine Journal. https://doi.org/10.1507/endocrj.ej23-0282

Vancouver

Matoba K. Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap. Endocrine Journal. 2023. doi:10.1507/endocrj.ej23-0282

BibTeX
@article{Matoba2023,
  author = {Matoba, Keiichiro},
  title = {Deciphering Rho-associated, coiled-coil-containing protein kinase in diabetic nephropathy: small steps towards a giant leap},
  journal = {Endocrine Journal},
  year = {2023},
  doi = {10.1507/endocrj.ej23-0282}
}
Kostenlos starten →